Miho Hanamura

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Zoledronic acid (ZDA) is commonly prescribed to treat and prevent skeletal complications in patients with multiple myeloma or bone metastases. Although hypocalcemia often develops by ZDA, there is(More)
  • 1